Molecular and Phenotypic Characterization Revealed High Prevalence of Multidrug-Resistant Methicillin-Susceptible Staphylococcus aureus in Chongqing, Southwestern China

Microb Drug Resist. 2017 Mar;23(2):241-246. doi: 10.1089/mdr.2016.0078. Epub 2016 Oct 18.

Abstract

Methicillin-susceptible Staphylococcus aureus (MSSA) accounts for ∼40% of staphylococcal infections in China. However, the molecular characterization of MSSA is not well described. In this study, 124 MSSA strains collected in 2013 from a comprehensive teaching hospital in Chongqing, Southwestern China, were subjected to antibiotics susceptibility testing and molecular typing, including multilocus sequence typing, staphylococcal protein A (spa) gene typing, accessory gene regulator (agr) typing, pulsed-field gel electrophoresis (PFGE) typing, Panton-Valentine leukocidin (pvl) gene detection, and antibiotic-resistant gene detection. MSSA strains exhibited high genetic heterogeneity. A total of 10 PFGE groups, 26 sequence types, and 47 spa types were identified. Type I (62.9%) was the most frequent agr type, followed by type II (15.3%), type IV (11.3%), and type III (10.5%). The prevalence of pvl genes was 27.4% (34/124). Notably, 44.4% (55/124) of MSSA strains were multidrug resistance (MDR), and MDR isolates were mostly resistant to penicillin, erythromycin, and clindamycin. The resistance gene blaZ was present in 84.7% of strains, ermC was present in 85.5% of strains, ermA was present in 28.2% of strains, tetK was present in 16.1% of strains, tetM was present in 6.5% of strains, and aacA-aphD was present in 2.6% of strains. These data demonstrated the high prevalence of MDR MSSA in Chongqing, thereby indicating the need to control MSSA infection.

Keywords: Staphylococcus aureus; epidemiology; molecular characterization; resistance.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Toxins / genetics
  • Bacterial Typing Techniques / methods
  • China / epidemiology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Exotoxins / genetics
  • Humans
  • Leukocidins / genetics
  • Methicillin / therapeutic use*
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Methicillin-Resistant Staphylococcus aureus / genetics*
  • Microbial Sensitivity Tests / methods
  • Molecular Epidemiology / methods
  • Multilocus Sequence Typing / methods
  • Prevalence
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / epidemiology*

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
  • Methicillin